Researching &
developing therapies to outsmart cancer, turning its own weapons against itself

We're on it.

CytomX is a different kind of clinical-stage biopharmaceutical company – intent on revolutionizing the way we treat cancer. Our distinctive Probody® therapeutics are progressing through the clinic with the promise of unlocking the full potential of more potent, less toxic anti-cancer medications. Our ultimate goal is to bring a new generation of life-changing treatment options to patients.

Broad, clinical-stage pipeline

With multiple Probody programs in the clinic, our aim is to transform cancer treatment and patients’ lives.

Learn More

Bold innovators wanted

We are obsessed with treating cancer, and we are looking for dedicated individuals to join us as we pioneer our new approaches to bring patients the treatment they need. Interested in joining CytomX’s diverse team of professionals in our pursuit of destroying cancer, differently?

Learn More

DEI statement

CytomX embraces diversity and seeks to enhance and maintain our culture of equity and inclusion which encourages individuals to be themselves, feel involved, respected, and connected.

We at CytomX believe that we benefit from each other’s ideas and experiences. We accept our differences and learn from one another, improve together, and embrace change to achieve our corporate and individual objectives. This belief applies to how we work together at CytomX, how we work with others outside CytomX, how we represent CytomX in our communities, and how we endeavor to bring our scientific innovations to a diverse patient population.

CytomX acknowledges the importance of diversity, equity, and inclusion initiatives and that they require an evolving and ongoing commitment.

CytomX is an equal opportunity employer and does not discriminate against any individual or potential candidate because of race, color, religion, sex, national origin, sexual preference, or any other legally protected category.

"The extraordinary innovation within the CytomX pipeline is driven by our passionate team and our dedication to destroying cancer, differently. The word “different” is also deeply embraced by CytomX in our commitment to diversity, equity, and inclusion. We are extremely proud of the cultural diversity across our organization. "

—Sean McCarthy, Chief Executive Officer and Chairman